ISOSULFAN_BLUE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Isosulfan_blue, and what generic alternatives are available?
Isosulfan_blue is a drug marketed by Am Regent, Eugia Pharma, Fresenius Kabi Usa, Meitheal, MSN, Mylan Institutional, Saba Ilay Sanayi, and Somerset Theraps Llc. and is included in eight NDAs.
The generic ingredient in ISOSULFAN_BLUE is isosulfan blue. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the isosulfan blue profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isosulfan_blue
A generic version of ISOSULFAN_BLUE was approved as isosulfan blue by MYLAN INSTITUTIONAL on July 20th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ISOSULFAN_BLUE?
- What are the global sales for ISOSULFAN_BLUE?
- What is Average Wholesale Price for ISOSULFAN_BLUE?
Summary for ISOSULFAN_BLUE
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 8 |
| Finished Product Suppliers / Packagers: | 4 |
| Drug Prices: | Drug price information for ISOSULFAN_BLUE |
| DailyMed Link: | ISOSULFAN_BLUE at DailyMed |
US Patents and Regulatory Information for ISOSULFAN_BLUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Am Regent | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 210294-001 | May 17, 2023 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan Institutional | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 090874-003 | Jan 28, 2026 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Meitheal | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 213130-001 | Nov 3, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Mylan Institutional | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 090874-001 | Jul 20, 2010 | AP | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Eugia Pharma | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 206831-001 | Feb 2, 2016 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | ISOSULFAN BLUE | isosulfan blue | SOLUTION;SUBCUTANEOUS | 211869-001 | Sep 8, 2022 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
